Dawoon Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Dawoon Jeong has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Hongjo Choi
Division of Health Policy and Management, Korea University College of Health Science, Seoul, Republic of Korea
10 shared publications - Young Ae Kang
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
8 shared publications - Doosoo Jeon
Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea
5 shared publications - Hee-Yeon Kang
Department of Public Health & AI, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea
4 shared publications - Hee-Sun Kim
Department of Health Policy Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea
3 shared publications - Hojoon Sohn
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
3 shared publications
Latest Publications
- Open Access
- 13 December 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025071
Cohort profile: the KDCA-Tuberculosis-NHIS cohort linking tuberculosis surveillance and health insurance data in Korea
Despite a steady decline in incidence, tuberculosis (TB) remains a substantial public health burden in Korea, particularly among older adults. Existing national TB surveillance systems lack sufficiently comprehensive data to assess long-term outcomes and health disparities. The K-TB-N cohort integrates data from 3 national sources: the Korean Tuberculosis Surveillance System (2011-2022), the National Health Insurance Database (2010-2022), and mortality data from Statistics Korea (2010-2022). After data cleaning and linkage, the final cohort included 373,812 patients (375,440 episodes) with either drug-susceptible TB or drug- resistant TB. TB notifications declined by approximately 60% over the study period, while the median patient age continued to rise. Treatment success improved over time, accompanied by reductions in lost to follow-up. However, mortality during treatment increased, with more than half of deaths attributed to non-TB causes such as pneumonia, cancer, and cardiovascular disease. Post-treatment mortality also remained high, particularly among patients with drug-resistant TB. The K-TB-N cohort provides a comprehensive, linked dataset for advancing research on TB epidemiology, treatment outcomes, comorbidities, and health disparities. It enables evaluations of public health interventions, long-term prognosis, and strategies for post-TB care. This cohort will remain a valuable resource for shaping data-driven TB control policies in aging and high-burden settings.
- 13 December 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025071
Open AccessCohort profile: the KDCA-Tuberculosis-NHIS cohort linking tuberculosis surveillance and health insurance data in Korea
Despite a steady decline in incidence, tuberculosis (TB) remains a substantial public health burden in Korea, particularly among older adults. Existing national TB surveillance systems lack sufficiently comprehensive data to assess long-term outcomes and health disparities. The K-TB-N cohort integrates data from 3 national sources: the Korean Tuberculosis Surveillance System (2011-2022), the National Health Insurance Database (2010-2022), and mortality data from Statistics Korea (2010-2022). After data cleaning and linkage, the final cohort included 373,812 patients (375,440 episodes) with either drug-susceptible TB or drug- resistant TB. TB notifications declined by approximately 60% over the study period, while the median patient age continued to rise. Treatment success improved over time, accompanied by reductions in lost to follow-up. However, mortality during treatment increased, with more than half of deaths attributed to non-TB causes such as pneumonia, cancer, and cardiovascular disease. Post-treatment mortality also remained high, particularly among patients with drug-resistant TB. The K-TB-N cohort provides a comprehensive, linked dataset for advancing research on TB epidemiology, treatment outcomes, comorbidities, and health disparities. It enables evaluations of public health interventions, long-term prognosis, and strategies for post-TB care. This cohort will remain a valuable resource for shaping data-driven TB control policies in aging and high-burden settings.
- Open Access
- 12 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0334961
Impact of active tuberculosis on social mobility and its gender differences: Difference in differences using nationwide tuberculosis surveillance data and national health insurance data
Although reducing catastrophic total costs caused by TB is a major public health concern, there is a scarcity of long-term follow-up studies on social suffering due to TB as well as studies examining gender gaps. This study aims to examine the degree of long-term change in household incomes due to active TB by gender. We created data for the TB and control groups by linking the Korean National Tuberculosis Surveillance System (KNTSS) and National Health Information Database (NHID) and covariate-adjusted propensity score matching (PSM). We created longitudinal panel data from two years before TB diagnosis (t) to two years after TB diagnosis and analyzed the changes in household income deciles by gender and group using a difference in differences (DID) model. In men, there was a clear trend of declining income since time t in the TB group (DID coefficient = −0.131 95% CI = −0.132 ~ −0.129), but there was no marked change in women. Subgroup analyses on the working-age population (20–65 years) (DID coefficient = −0.053, 95% CI = −0.096 ~ −0.010) and employee population (DID coefficient = −0.072, 95% CI = −0.110 ~ −0.034) showed a trend of declining income in the female TB group. This study showed that there is a marked trend of declining income due to the diagnosis and treatment of active TB in men but not in women. This discrepancy may be attributable to the differences in gender roles in a patriarchal society and higher possibility of women moving out of the labor market after disease. There is a pressing need for comprehensive and universal implementation of health and social protection policies to alleviate the trend of social suffering caused by disease.
- 12 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0334961
Open AccessImpact of active tuberculosis on social mobility and its gender differences: Difference in differences using nationwide tuberculosis surveillance data and national health insurance data
Although reducing catastrophic total costs caused by TB is a major public health concern, there is a scarcity of long-term follow-up studies on social suffering due to TB as well as studies examining gender gaps. This study aims to examine the degree of long-term change in household incomes due to active TB by gender. We created data for the TB and control groups by linking the Korean National Tuberculosis Surveillance System (KNTSS) and National Health Information Database (NHID) and covariate-adjusted propensity score matching (PSM). We created longitudinal panel data from two years before TB diagnosis (t) to two years after TB diagnosis and analyzed the changes in household income deciles by gender and group using a difference in differences (DID) model. In men, there was a clear trend of declining income since time t in the TB group (DID coefficient = −0.131 95% CI = −0.132 ~ −0.129), but there was no marked change in women. Subgroup analyses on the working-age population (20–65 years) (DID coefficient = −0.053, 95% CI = −0.096 ~ −0.010) and employee population (DID coefficient = −0.072, 95% CI = −0.110 ~ −0.034) showed a trend of declining income in the female TB group. This study showed that there is a marked trend of declining income due to the diagnosis and treatment of active TB in men but not in women. This discrepancy may be attributable to the differences in gender roles in a patriarchal society and higher possibility of women moving out of the labor market after disease. There is a pressing need for comprehensive and universal implementation of health and social protection policies to alleviate the trend of social suffering caused by disease.
- Open Access
- 31 May 2025
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 58 (3) , 317-325
Vulnerability Assessment and Enhanced Community-based Care and Management of Patients With Tuberculosis in Korea: A Crossover Design
Objectives: People-centered care and social protection are critical for improving tuberculosis (TB) treatment outcomes. This study aimed to evaluate whether a vulnerability assessment tool, developed for an enhanced community-based care and management (ECCM) program in 2 Korean cities, could predict and improve final TB treatment outcomes based on patients’ vulnerability levels.Methods: Treatment outcomes in the ECCM group were compared with those in a control group, stratified by vulnerability level. During stage 1, one city served as the intervention region and the other as the control, with a crossover in stage 2. The vulnerability assessment included all notified patients with TB, and those identified as highly vulnerable in the intervention group received social support following a consultation with a case manager.Results: The vulnerability assessment tool demonstrated moderate predictive ability for unfavorable outcomes, with an area under the curve of 0.70 (95% confidence interval, 0.63 to 0.77). The patients with high vulnerability who received ECCM treatment demonstrated a 19.8-percentage point (%p) higher treatment success rate than the high vulnerability subcategory of the control group. ECCM also appeared to reduce loss to follow-up and TB-related mortality by 8.4%p and 7.3%p, respectively, although these findings should be interpreted with caution.Conclusions: The results suggest that providing social support tailored to patient vulnerability at the time of diagnosis could improve TB treatment outcomes.
- 31 May 2025
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 58 (3) , 317-325
Open AccessVulnerability Assessment and Enhanced Community-based Care and Management of Patients With Tuberculosis in Korea: A Crossover Design
Objectives: People-centered care and social protection are critical for improving tuberculosis (TB) treatment outcomes. This study aimed to evaluate whether a vulnerability assessment tool, developed for an enhanced community-based care and management (ECCM) program in 2 Korean cities, could predict and improve final TB treatment outcomes based on patients’ vulnerability levels.Methods: Treatment outcomes in the ECCM group were compared with those in a control group, stratified by vulnerability level. During stage 1, one city served as the intervention region and the other as the control, with a crossover in stage 2. The vulnerability assessment included all notified patients with TB, and those identified as highly vulnerable in the intervention group received social support following a consultation with a case manager.Results: The vulnerability assessment tool demonstrated moderate predictive ability for unfavorable outcomes, with an area under the curve of 0.70 (95% confidence interval, 0.63 to 0.77). The patients with high vulnerability who received ECCM treatment demonstrated a 19.8-percentage point (%p) higher treatment success rate than the high vulnerability subcategory of the control group. ECCM also appeared to reduce loss to follow-up and TB-related mortality by 8.4%p and 7.3%p, respectively, although these findings should be interpreted with caution.Conclusions: The results suggest that providing social support tailored to patient vulnerability at the time of diagnosis could improve TB treatment outcomes.
- Open Access
- 28 May 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
The impact of population ageing on tuberculosis incidence, mortality, and case fatality in South Korea: a nationwide retrospective study
Background: This study investigated the effect of population ageing on the epidemiology of tuberculosis (TB) in South Korea. Methods: We conducted a retrospective cohort study using an integrated database from three national databases. We analysed trends in age-specific TB incidence, mortality, case fatality rates and risk factors for all-cause mortality among 328 637 patients with drug-susceptible TB from 2011 to 2020. Results: From 2011 to 2020, the proportion of patients aged ≥65 years increased from 30.5% to 50.7% of TB cases and from 74.3% to 86.8% of deaths. The TB incidence rate decreased from 90.3 to 39.5 per 100 000 (average annual per cent change (AAPC) −8.5%; 95% confidence interval (CI) −9.2 to −7.7). The crude mortality rate remained largely unchanged, shifting from 4.6 to 5.4 per 100 000 (AAPC 1.6%; 95% CI −0.1 to 3.1). The case fatality rate increased from 5.1% to 13.5% (AAPC 11.3%; 95% CI 10.5 to 12.1). Although incidence and mortality declined across all age groups, the rate of decline slowed with increasing age. Patients aged ≥80 years showed the slowest decline in incidence (AAPC −4.3%; 95% CI −5.4 to −3.5) and stagnation in mortality (AAPC 0.5%; 95% CI −1.4 to 2.2). Conclusions: This study highlights the challenges of population ageing on TB control, including increasing case fatality rates and slower declines in TB incidence and mortality. These findings call for a reassessment of current strategies to address the needs of the elderly.
- 28 May 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
Open AccessThe impact of population ageing on tuberculosis incidence, mortality, and case fatality in South Korea: a nationwide retrospective study
Background: This study investigated the effect of population ageing on the epidemiology of tuberculosis (TB) in South Korea. Methods: We conducted a retrospective cohort study using an integrated database from three national databases. We analysed trends in age-specific TB incidence, mortality, case fatality rates and risk factors for all-cause mortality among 328 637 patients with drug-susceptible TB from 2011 to 2020. Results: From 2011 to 2020, the proportion of patients aged ≥65 years increased from 30.5% to 50.7% of TB cases and from 74.3% to 86.8% of deaths. The TB incidence rate decreased from 90.3 to 39.5 per 100 000 (average annual per cent change (AAPC) −8.5%; 95% confidence interval (CI) −9.2 to −7.7). The crude mortality rate remained largely unchanged, shifting from 4.6 to 5.4 per 100 000 (AAPC 1.6%; 95% CI −0.1 to 3.1). The case fatality rate increased from 5.1% to 13.5% (AAPC 11.3%; 95% CI 10.5 to 12.1). Although incidence and mortality declined across all age groups, the rate of decline slowed with increasing age. Patients aged ≥80 years showed the slowest decline in incidence (AAPC −4.3%; 95% CI −5.4 to −3.5) and stagnation in mortality (AAPC 0.5%; 95% CI −1.4 to 2.2). Conclusions: This study highlights the challenges of population ageing on TB control, including increasing case fatality rates and slower declines in TB incidence and mortality. These findings call for a reassessment of current strategies to address the needs of the elderly.
- Open Access
- 26 February 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (5) , 102723
Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011–2020
- 26 February 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (5) , 102723
Open AccessDisagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011–2020
- Open Access
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (1) , 16-24
Comparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South Korea
Choi H, et al. Yonsei Med J. 2025 Jan;66(1):16-24. https://doi.org/10.3349/ymj.2024.0048
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (1) , 16-24
Open AccessComparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South Korea
Choi H, et al. Yonsei Med J. 2025 Jan;66(1):16-24. https://doi.org/10.3349/ymj.2024.0048
- Open Access
- 12 September 2024
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 46, e2024076
Homelessness and mortality: gender, age, and housing status inequity in Korea
OBJECTIVES: We compared mortality rates among various housing statuses within the homeless population and investigated factors contributing to their deaths, including housing status, gender, and age.METHODS: Using a comprehensive multi-year dataset (n=15,445) curated by the National Tuberculosis Screening and Case Management Programs, matched with the 2019-2021 Vital Statistics Death Database and National Health Insurance claims data, we calculated age-standardized mortality rates and conducted survival analysis to estimate differences in mortality rates based on housing status.RESULTS: The mortality rate among the homeless population was twice as high as that of the general population, at 1,159.6 per 100,000 compared to 645.8 per 100,000, respectively. Cancer and cardiovascular diseases were the primary causes of death. Furthermore, individuals residing in shelter facilities faced a significantly higher risk of death than those who were rough sleeping, with an adjusted hazard ratio of 1.70 (95% confidence interval, 1.37 to 2.11). This increased risk was especially pronounced in older adults and women.CONCLUSIONS: The study highlights the urgent need for targeted interventions, as the homeless population faces significantly higher mortality rates. Older adults and women in shelter facilities are at the highest risk.
- 12 September 2024
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 46, e2024076
Open AccessHomelessness and mortality: gender, age, and housing status inequity in Korea
OBJECTIVES: We compared mortality rates among various housing statuses within the homeless population and investigated factors contributing to their deaths, including housing status, gender, and age.METHODS: Using a comprehensive multi-year dataset (n=15,445) curated by the National Tuberculosis Screening and Case Management Programs, matched with the 2019-2021 Vital Statistics Death Database and National Health Insurance claims data, we calculated age-standardized mortality rates and conducted survival analysis to estimate differences in mortality rates based on housing status.RESULTS: The mortality rate among the homeless population was twice as high as that of the general population, at 1,159.6 per 100,000 compared to 645.8 per 100,000, respectively. Cancer and cardiovascular diseases were the primary causes of death. Furthermore, individuals residing in shelter facilities faced a significantly higher risk of death than those who were rough sleeping, with an adjusted hazard ratio of 1.70 (95% confidence interval, 1.37 to 2.11). This increased risk was especially pronounced in older adults and women.CONCLUSIONS: The study highlights the urgent need for targeted interventions, as the homeless population faces significantly higher mortality rates. Older adults and women in shelter facilities are at the highest risk.
- Open Access
- 12 December 2023
- Published by Elsevier in Public Health
- Vol. 226, 228-236
Low household income increases the risk of tuberculosis recurrence: a retrospective nationwide cohort study in South Korea
- 12 December 2023
- Published by Elsevier in Public Health
- Vol. 226, 228-236
Open AccessLow household income increases the risk of tuberculosis recurrence: a retrospective nationwide cohort study in South Korea
- Open Access
- 15 June 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (4)
Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis
Background: This study evaluated the risk factors of long-term mortality in patients with multidrug/rifampicin-resistant tuberculosis (MDR/RR-TB) in South Korea who were lost to follow-up (LTFU).Methods: This was a retrospective longitudinal follow-up study using an integrated database constructed by data linkage of the three national databases, which included 7226 cases of MDR/RR-TB notified between 2011 and 2017 in South Korea. Post-treatment outcomes of patients who were LTFU were compared with those of patients who achieved treatment success.Results: Of the 7226 MDR/RR-TB cases, 730 (10.1%) were LTFU. During a median follow-up period of 4.2 years, 101 (13.8%) of the LTFU patients died: 25 deaths (3.4%) were TB related and 76 (10.4%) were non-TB related. In the LTFU group, the adjusted hazard ratio (aHR) of all-cause mortality (aHR 2.50, 95% CI 1.99–3.15, p<0.001), TB-related mortality (aHR 5.38, 95% CI 3.19–9.09, p<0.001) and non-TB-related mortality (HR 2.21, 95% CI 1.70–2.87, p55 years, fluoroquinolone resistance, cancer and no retreatment. In the LTFU patients who did not receive retreatment, the risk of non-TB-related mortality (aHR 5.00, 95% CI 1.53–16.37, p=0.008) and consequent all-cause mortality (aHR 2.18, 95% CI 1.08–4.40, p=0.030) was significantly higher than that of patients who received retreatment.Conclusion: Non-TB-related mortality was the main cause of death and might be reduced by retreatment in LTFU patients with MDR/RR-TB.
- 15 June 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (4)
Open AccessRetreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis
Background: This study evaluated the risk factors of long-term mortality in patients with multidrug/rifampicin-resistant tuberculosis (MDR/RR-TB) in South Korea who were lost to follow-up (LTFU).Methods: This was a retrospective longitudinal follow-up study using an integrated database constructed by data linkage of the three national databases, which included 7226 cases of MDR/RR-TB notified between 2011 and 2017 in South Korea. Post-treatment outcomes of patients who were LTFU were compared with those of patients who achieved treatment success.Results: Of the 7226 MDR/RR-TB cases, 730 (10.1%) were LTFU. During a median follow-up period of 4.2 years, 101 (13.8%) of the LTFU patients died: 25 deaths (3.4%) were TB related and 76 (10.4%) were non-TB related. In the LTFU group, the adjusted hazard ratio (aHR) of all-cause mortality (aHR 2.50, 95% CI 1.99–3.15, p<0.001), TB-related mortality (aHR 5.38, 95% CI 3.19–9.09, p<0.001) and non-TB-related mortality (HR 2.21, 95% CI 1.70–2.87, p55 years, fluoroquinolone resistance, cancer and no retreatment. In the LTFU patients who did not receive retreatment, the risk of non-TB-related mortality (aHR 5.00, 95% CI 1.53–16.37, p=0.008) and consequent all-cause mortality (aHR 2.18, 95% CI 1.08–4.40, p=0.030) was significantly higher than that of patients who received retreatment.Conclusion: Non-TB-related mortality was the main cause of death and might be reduced by retreatment in LTFU patients with MDR/RR-TB.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (5) , e33
Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST)
Choi H, et al. J Korean Med Sci. 2023 Jan;38(5):e33. https://doi.org/10.3346/jkms.2023.38.e33
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (5) , e33
Open AccessNationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST)
Choi H, et al. J Korean Med Sci. 2023 Jan;38(5):e33. https://doi.org/10.3346/jkms.2023.38.e33